| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.6 |